B

Work With Us

B

Work With Us

B

Work With Us

01

Lymphatic Delivery with Pembrolizumab

MedTech

Clinical

Pipeline

02

TROP-2 ADC in TNBC and HR+/HER2– Breast Cancer

Biotech

Clinical

Scientific

03

CD38 Therapy in Relapsed/Refractory Multiple Myeloma

Biotech

Preclinical

Pipeline

04

TROP-2 ADC in First-Line TNBC

Biotech

Clinical

Pipeline

05

Menin Inhibitor in Type 1 Diabetes

Biotech

Clinical

Pipeline

06

Elevating Lymphatic Delivery in Immunology and Oncology

MedTech

Clinical

Scientific

07

Next-Gen Anticoagulant Therapy

Biotech

Clinical

Product

08

TROP-2 ADC in HR+/HER2– Breast Cancer

Biotech

Clinical

Medical

09

Next-Generation Oral GLP-1 Receptor Agonist

Biotech

Clinical

Product

10

Genetic Interaction Mapping Platform

TechBio

Series B

Medical

11

BD Strategy for Biologics Delivery

MedTech

Clinical

Medical

12

ADC in Prostate Cancer

Biotech

Preclinical

Medical

01

Lymphatic Delivery with Pembrolizumab

MedTech

Pipeline

02

TROP-2 ADC in TNBC and HR+/HER2– Breast Cancer

Biotech

Scientific

03

CD38 Therapy in Relapsed/Refractory Multiple Myeloma

Biotech

Pipeline

04

TROP-2 ADC in First-Line TNBC

Biotech

Pipeline

05

Menin Inhibitor in Type 1 Diabetes

Biotech

Pipeline

06

Elevating Lymphatic Delivery in Immunology and Oncology

MedTech

Scientific

07

Next-Gen Anticoagulant Therapy

Biotech

Product

08

TROP-2 ADC in HR+/HER2– Breast Cancer

Biotech

Medical

09

Next-Generation Oral GLP-1 Receptor Agonist

Biotech

Product

10

Genetic Interaction Mapping Platform

TechBio

Medical

11

BD Strategy for Biologics Delivery

MedTech

Medical

12

ADC in Prostate Cancer

Biotech

Medical

01

Lymphatic Delivery with Pembrolizumab

MedTech

Pipeline

Emerging MedTech

02

TROP-2 ADC in TNBC and HR+/HER2– Breast Cancer

Biotech

Scientific

Emerging Biopharma

03

CD38 Therapy in Relapsed/Refractory Multiple Myeloma

Biotech

Pipeline

Emerging Biopharma

04

TROP-2 ADC in First-Line TNBC

Biotech

Pipeline

Emerging Biopharma

05

Menin Inhibitor in Type 1 Diabetes

Biotech

Pipeline

Emerging Biotech

06

Elevating Lymphatic Delivery in Immunology and Oncology

MedTech

Scientific

Emerging MedTech

07

Next-Gen Anticoagulant Therapy

Biotech

Product

Emerging Biotech

08

TROP-2 ADC in HR+/HER2– Breast Cancer

Biotech

Medical

Emerging Biotech

09

Next-Generation Oral GLP-1 Receptor Agonist

Biotech

Product

Emerging Biotech

09

BD Strategy for Biologics Delivery

MedTech

Medical

Emerging MedTech

09

Genetic Interaction Mapping Platform

TechBio

Medical

Emerging TechBio

09

ADC in Prostate Cancer

Biotech

Medical

Emerging Biopharma